SUPPRESSA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 5.987
AS - Asia 2.911
EU - Europa 2.172
SA - Sud America 776
AF - Africa 159
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.009
Nazione #
US - Stati Uniti d'America 5.824
SG - Singapore 1.236
BR - Brasile 632
CN - Cina 585
IT - Italia 402
HK - Hong Kong 363
RU - Federazione Russa 363
DE - Germania 296
SE - Svezia 286
VN - Vietnam 242
FR - Francia 180
FI - Finlandia 160
GB - Regno Unito 140
UA - Ucraina 97
IN - India 93
BD - Bangladesh 81
CA - Canada 80
ID - Indonesia 54
NL - Olanda 51
CI - Costa d'Avorio 49
MX - Messico 49
AR - Argentina 38
IQ - Iraq 37
PK - Pakistan 36
JP - Giappone 34
ZA - Sudafrica 33
ES - Italia 31
CO - Colombia 29
BE - Belgio 26
TR - Turchia 26
AT - Austria 24
CL - Cile 24
MA - Marocco 22
SA - Arabia Saudita 21
PL - Polonia 20
IE - Irlanda 18
CZ - Repubblica Ceca 16
UZ - Uzbekistan 16
LT - Lituania 15
EC - Ecuador 14
VE - Venezuela 13
PH - Filippine 12
JO - Giordania 10
NP - Nepal 10
PY - Paraguay 10
TN - Tunisia 10
EG - Egitto 9
MY - Malesia 8
BG - Bulgaria 7
KE - Kenya 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
DZ - Algeria 6
KG - Kirghizistan 6
UY - Uruguay 6
BO - Bolivia 5
BY - Bielorussia 5
ET - Etiopia 5
GR - Grecia 5
JM - Giamaica 5
PT - Portogallo 5
AZ - Azerbaigian 4
HN - Honduras 4
IL - Israele 4
PA - Panama 4
PE - Perù 4
SN - Senegal 4
AO - Angola 3
AU - Australia 3
BB - Barbados 3
CH - Svizzera 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LB - Libano 3
LY - Libia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
GE - Georgia 2
GT - Guatemala 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
QA - Qatar 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GF - Guiana Francese 1
HR - Croazia 1
IR - Iran 1
Totale 11.994
Città #
Ashburn 717
Singapore 628
Fairfield 553
Chandler 484
San Jose 371
Woodbridge 368
Hong Kong 363
Seattle 222
Houston 221
Nyköping 219
Jacksonville 215
Cambridge 191
Wilmington 174
Beijing 173
Ann Arbor 141
New York 140
Helsinki 96
Los Angeles 93
Dallas 91
Lauterbourg 89
Lawrence 87
Roxbury 84
Ho Chi Minh City 60
Santa Clara 60
Boardman 59
Munich 59
Bari 58
Nanjing 58
Des Moines 53
São Paulo 50
Abidjan 49
Hanoi 46
Dearborn 42
Brooklyn 40
Jakarta 38
Frankfurt am Main 36
Princeton 35
Inglewood 34
London 34
Council Bluffs 33
Buffalo 32
Dong Ket 31
Tokyo 30
Nanchang 27
Nuremberg 25
Ostuni 25
Paris 25
Brussels 24
Moscow 23
Rio de Janeiro 23
San Diego 23
Falkenstein 21
Rome 20
Hebei 19
Johannesburg 19
Shenyang 19
Toronto 19
Montreal 18
Napoli 18
Amsterdam 17
Chennai 17
Chicago 17
Denver 17
Dublin 17
San Francisco 17
Belo Horizonte 16
Shanghai 16
Columbus 15
Mexico City 15
Milan 15
Phoenix 15
The Dalles 15
Jiaxing 13
Orem 13
Pune 13
Salvador 13
Tashkent 13
Changsha 12
Haiphong 12
Kunming 12
Lahore 12
Manchester 12
Taranto 12
Atlanta 11
Curitiba 11
Tianjin 11
Turku 11
Amman 10
Campinas 10
Dhaka 10
Guangzhou 10
Mumbai 10
Warsaw 10
Boston 9
Guarulhos 9
Poplar 9
Redwood City 9
Vienna 9
Washington 9
Baghdad 8
Totale 7.517
Nome #
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 217
Real-world efficacy and safety of Inclisiran: a prospective cohort study 210
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 202
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 202
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 200
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 193
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 183
Asymptomatic microhematuria: an indication of hereditary hemorrhagic telangiectasia? 180
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 177
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 171
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 167
Biliary Cystadenoma in a Female Patient with HCV-Related Liver Cirrhosis: A Case Report 167
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 167
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 166
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 165
Capillaroscopy of the dorsal skin of the hands in hereditary hemorrhagic telangiectasia 164
"A secret agent" for HHT: asyntomatyc microhematuria 161
Congenital analbuminemia in a patient affected by hypercholesterolemia: A case report 158
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 156
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 154
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type 154
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 153
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 152
HHT: a rare disease with broad spectrum of clinical aspects 147
The clinical labyrinth of chronic granulomatous diseases: not only sarcoidosis 145
"A secret Weapon" for diagnosis of HHT: the echo-color-Doppler study of the liver 139
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. 135
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 135
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 133
Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2 132
Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia. 128
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects 126
A new application for capillaroscopy: the study of dorsal surfaces of the hands in HHT 122
Hereditary Hemorrhagic Telangiectasia: a 15-year shorter life span 118
Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: Echo-color-Doppler vs multislice computed tomography study 118
Neuroimmune activation in chronic heart failure 118
13c-methacetin breath test: a new diagnostic tool for diagnosis of liver involvement in patients affected by hereditary hemorrhagic telangiectasia 117
DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population 115
Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation 115
Abdominal obesity negatively influences key metrics of reverse cholesterol transport 114
Hereditary Hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers 111
Orofacial hereditary haemorrhagic telangiectasia: High power diode laser in early and advanced lesion treatment 109
Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease 108
Hypogonadotropic hypogonadism associated with hereditary hemorrhagic telangiectasia 107
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia 104
Homozygous familial hypercholesterolemia in a young woman with dual gene mutations of low-density lipoprotein receptor and proprotein convertase subtilisin/kexin type 9 104
Monocyte-to-HDL Ratio (MHR) Predicts Vitamin D Deficiency in Healthy and Metabolic Women: A Cross-Sectional Study in 1048 Subjects 104
Diet and myocardial infarction: a nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 103
Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia 102
Pain and Frailty in Hospitalized Older Adults 101
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 100
Asymptomatic microhematuria: a spy of Hereditary Hemorrhagic Teleangiectasia (HHT)? 99
Pulmonary Arteriovenous Malformations and Cerebral Abscess Recurrence in a Child With Hereditary Hemorrhagic Telangiectasia. 98
Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician 96
The arduous challenge of seeking for biomarkers in rare diseases 95
Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab 95
Hereditary hemorrhagic teleangiectasia: a 15-year shorter life span 94
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 93
Adipocyte fatty acid-binding protein 4 e iperlipemia familiare combinata 92
Rare diseases in the elderly: a new perspective for the specialist in geriatrics 91
Capillaroscopic Patterns in Patients With HHT 88
Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? 88
The lower is better”: genetic pitfalls of a paradigmatic approach for dyslipidemia 88
Improvement of the diagnostic accuracy of the liver shunts in hereditary hemorrhagic teleangiectasia 85
Life expectancy in patients with hereditary haemorrhagic telangiectasia 85
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 82
What changed in the Italian internal medicine and geriatric wards during the lockdown 82
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 81
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 81
Hyperhomocysteinemia is linked to MASLD 80
Thyroid nodule malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects 78
HHT Oro-facial manifestations: histopathological and confocal laser scanning microscopy analysis 78
IDENTIFICATION AND VALIDATION OF THE CHRONO MED DIET SCORE: A SURVEY IN 9200 SUBJECTS 75
Sarcoidosis and autoimmunity: In the depth of a complex relationship 75
Association of fT4 and TSH with insulin resistance in aged obese euthyroid people 74
Clinical features of eng- and alk1- mutation carriers 74
Ultrasonographic analysis of HAVMS in a large cohort of hereditary hemorrhagic telangiectasia patients: definition of a new highly-accurate intrahepatic parameter 74
European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT) 74
COGNITIVE FUNCTIONS, MOOD STATE AND QUALITY OF LIFE IN PATIENTS WITH HHT 72
null 72
Characterization of circulating endothelial cells in Hereditary Haemorrhagic Telangiectasia 71
Studio longitudinale dell'evoluzione in età evolutiva delle malformazioni arterovenoso nella teleangiectasia emorragica ereditaria 71
Gli ammalati di Teleangiectasia Emorragica Ereditaria vivono in media 15 anni meno rispetto ai loro partners non affetti 71
Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia 71
Il fenotipo hypertg-waist: impatto sul rischio cardiovascolare e sulla mortalità nella popolazione anziana. 69
Improvement of the diagnostic accuracy of liver shunts in Hereditary Hemorrhagic Telangiectasia 69
Correlazione genotipo-fenotipo nella popolazione italiana affetta da Rendu-Osler-Weber (o Teleangiectasia Emorragica Ereditaria) 67
Hereditary haemorrhagic telangiectasia: study of hepatic vascular alterations with multi-detector row helical CT and reconstruction programs 67
Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy 67
Rapida ed efficiente caratterizzazione di mutazioni in pazienti con Teleangiectasia Emorragica Ereditaria mediante DHPLC 66
Multi-slice-ct vs dynamic time-resolved mr-angiography for evaluation of hepatic involvement in hereditary hemorragic telangiectasia 64
Minimal portosystemic encephalopathy: A new nosological entity in patients with hereditary haemorrhagic telangiectasia 64
Uso dell’angio-RM dinamica nello studio delle alterazioni parenchimali epatiche nei pazienti affetti da HHT: esperienza preliminare 63
Simplex index of insulin resistance in Hereditary Haemorrhagic Telangiectasia (HHT) patients. Preliminary data. 63
Psycho-social effects regarding the job placement of hereditary hemorrhagic teleangectasia patients 62
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis 62
Diagnostic delay in rare diseases: the drama of a silent killer 61
Dynamic MR-angiography in the evaluation of hepatic involvement in hereditary hemorrhagic telangiectasia 61
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome 59
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care 58
Totale 11.074
Categoria #
all - tutte 53.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 0 66
2021/2022646 24 86 10 19 45 44 23 32 64 37 103 159
2022/20231.199 151 139 70 113 144 146 15 140 199 6 50 26
2023/2024558 36 95 39 50 49 106 25 59 7 23 18 51
2024/20252.305 94 44 132 84 93 201 248 241 94 125 318 631
2025/20264.541 734 280 313 496 582 289 477 126 544 465 171 64
Totale 12.352